Resistance mechanism to Notch inhibition and combination therapy in human T cell acute lymphoblastic leukemia
Preprint
Abstract
Gain-of-function mutations in NOTCH1 are among the most frequent genetic alterations in T cell acute lymphoblastic leukemia (T-ALL), making the Notch signaling pathway a promising therapeutic target for personalized medicine. Yet, a major limitation for long-term success of targeted therapy is relapse due to tumor heterogeneity or acquired resistance. Thus, we performed a genome-wide CRISPR-Cas9 screen to identify prospective resistance mechanisms to pharmacological NOTCH inhibitors and novel targeted combination therapies to efficiently combat T-ALL. Mutational loss of Phosphoinositide-3-Kinase regulatory subunit 1 (PIK3R1) causes resistance to Notch inhibition. PIK3R1 deficiency leads to increased PIK3/Akt signaling which regulates the cell cycle and spliceosome machinery, both at the transcriptional and post-translational level. Moreover, several therapeutic combinations have been identified, where simultaneous targeting of the cyclin-dependent kinases 4 and 6 (CDK4/6) and NOTCH proved to be the most efficacious in T-ALL xenotransplantation models. Key points: Mutational loss of PIK3R1 induces resistance to NOTCH1 inhibition in T-ALL Pharmacological Notch inhibition synergizes with CDK4/6 inhibitors in T-ALLKeywords
All Related Versions
- Published version: Blood Advances, 7 (20), 6240.
This publication has 33 references indexed in Scilit:
- Therapeutic Targeting of the Cyclin D3:CDK4/6 Complex in T Cell LeukemiaCancer Cell, 2012
- High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein StabilityCancer Discovery, 2011
- Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF lossBlood, 2010
- High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemiaBlood, 2009
- Phosphatidylinositol-3-Kinase as a Therapeutic Target in MelanomaClinical Cancer Research, 2009
- PI3K pathway alterations in cancer: variations on a themeOncogene, 2008
- Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemiaNature Medicine, 2007
- The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancerOncogene, 2007
- Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling NetworksCell, 2006
- Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic LeukemiaScience, 2004